Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 245-255

  Yan, Chenggong ^a   Wu, Yuankui ^a   Feng, Jie ^a   Chen, Wufan ^a   Liu, Xiang ^a   Hao, Peng ^a   Yang, Ruimeng ^b   Zhang, Juan ^a   Lin, Bingquan ^a   Xu, Yikai ^a   Liu, Ruiyuan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Avidin biotin; Contrast agents; Pretargeting; Superparamagnetic iron oxide nanoparticles

Indexed keywords

FERRIC FERROCYANIDE; IRON OXIDE; MACROGOL; MONOCLONAL ANTIBODY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; BREAST CANCER; BREAST CARCINOGENESIS; CANCER LOCALIZATION; CELL TRANSPORT; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOTOXICITY TEST; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; IN VIVO STUDY; MACROPHAGE; MOLECULAR IMAGING; MOUSE; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCESS DEVELOPMENT; SENSITIVITY AND SPECIFICITY;

AVIDIN-BIOTIN; CONTRAST AGENTS; PRETARGETING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL SURVIVAL; CONTRAST MEDIA; FEMALE; FERROCYANIDES; INTEGRIN ALPHAVBETA3; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; POLYETHYLENE GLYCOLS;

EID: 84872973160     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38678     Document Type: Article

References (34)

1. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401-410.
2. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2(2):91-100.
3. Morales-Avila E, Ferro-Flores G, Ocampo-García BE, et al. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor alpha(v)beta(3) expression. Bioconjug Chem. 2011;22(5):913-922.
4. Xie H, Diagaradjane P, Deorukhkar AA, et al. Integrin alphavbeta3targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int J Nanomedicine. 2011;6:259-269.
5. Lanzardo S, Conti L, Brioschi C, et al. A new optical imaging probe targeting alphaVbeta3integrin in glioblastoma xenografts. Contrast Media Mol Imaging. 2011;6(6):449-458.
6. Streeter JE, Gessner RC, Tsuruta J, Feingold S, Dayton PA. Assessment of molecular imaging of angiogenesis with three-dimensional ultrasonography. Mol Imaging. 2011;10(6):460-468.
7. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17(7):484-499.
8. Wahajuddin, Arora S. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine. 2012;7: 3445-3471.
9. Yu MK, Jeong YY, Park J, et al. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed Engl. 2008;47(29):5362-5365.
10. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18): 3995-4021.
11. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
12. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006;19(1):142-164.
13. Paganelli G, Magnani P, Zito F, et al. Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin. Eur J Nucl Med. 1994;21(4): 314-321.
14. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 1991;51(21):5960-5966.
15. Diamandis EP, Christopoulos TK. The biotin-(strept)avidin system: principles and applications in biotechnology. Clin Chem. 1991;37(5): 625-636.
16. De Cuyper M, Joniau M. Magnetoliposomes. Formation and structural characterization. Eur Biophys J. 1988;15(5):311-319.
17. Boles KS, Schmieder AH, Koch AW, et al. MR angiogenesis imaging with Robo4vs alphaVbeta3-targeted nanoparticles in a B16/F10mouse melanoma model. FASEB J. 2010;24(11):4262-4270.
18. van Tilborg GA, Mulder WJ, van der Schaft DW, et al. Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes. Neoplasia. 2008;10(12):1459-1469.
19. Li W, Su B, Meng S, et al. RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies. Eur J Radiol. 2011;80(2):598-606.
20. Bulte JW, de Cuyper M, Despres D, Frank JA. Shortvs long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J Magn Reson Imaging. 1999;9(2):329-335.
21. Efremova NV, Bondurant B, O'Brien DF, Leckband DE. Measurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chains. Biochemistry. 2000;39(12): 3441-3451.
22. Ding N, Lu Y, Lee RJ, et al. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Int J Nanomedicine. 2011;6:2513-2520.
23. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998;4(5):623-626.
24. Hsieh WJ, Liang CJ, Chieh JJ, et al. In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. Int J Nanomedicine. 2012;7:2833-2842.
25. Qiao J, Li S, Wei L, et al. HER2 targeted molecular MR imaging using a de novo designed protein contrast agent. PLoS One. 2011;6(3): e18103.
26. Schmieder AH, Caruthers SD, Zhang H, et al. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. FASEB J. 2008;22(12):4179-4189.
27. Esposito G, Geninatti Crich S, Aime S. Efficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agents. Chem Med Chem. 2008;3(12):1858-1862.
28. Sharkey RM, Karacay H, Cardillo TM, et al. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Clin Cancer Res. 2005;11(19 Pt 2):7109s-7121s.
29. Goodwin DA, Meares CF. Pretargeting: general principles; October 10-12, 1996. Cancer. 1997;80(Suppl 12):2675-2680.
30. Zhu W, Okollie B, Bhujwalla ZM, Artemov D. PAMAM dendrimerbased contrast agents for MR imaging of Her-2/neu receptors by a threestep pretargeting approach. Magn Reson Med. 2008;59(4):679-685.
31. Frascione D, Diwoky C, Almer G, et al. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes. Int J Nanomedicine. 2012;7:2349-2359.
32. Chen W, Jarzyna PA, van Tilborg GA, et al. RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 2010;24(6):1689-1699.
33. Mulder WJ, Strijkers GJ, Habets JW, et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J. 2005;19(14): 2008-2010.
34. Kluza E, Jacobs I, Hectors SJ, et al. Dual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J Control Release. 2012;158(2):207-214.